GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techno Drugs Ltd (DHA:TECHNODRUG) » Definitions » Change In Payables And Accrued Expense

Techno Drugs (DHA:TECHNODRUG) Change In Payables And Accrued Expense : BDT0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Techno Drugs Change In Payables And Accrued Expense?

Techno Drugs's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was BDT0 Mil. It means Techno Drugs's Accounts Payable & Accrued Expense stayed the same from Sep. 2024 to Dec. 2024 .

Techno Drugs's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was BDT0 Mil. It means Techno Drugs's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Techno Drugs Change In Payables And Accrued Expense Historical Data

The historical data trend for Techno Drugs's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techno Drugs Change In Payables And Accrued Expense Chart

Techno Drugs Annual Data
Trend
Change In Payables And Accrued Expense

Techno Drugs Quarterly Data
Sep23 Dec23 Sep24 Dec24
Change In Payables And Accrued Expense - - - -

Techno Drugs Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Techno Drugs Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Techno Drugs's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Techno Drugs Business Description

Industry
Traded in Other Exchanges
N/A
Address
31 Segun Bagicha, J K Tower, Dhaka, BGD, 1000
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.

Techno Drugs Headlines

No Headlines